Abu Dhabi, April 29 (Inditop.com/WAM) The United Arab Emirates (UAE) has asked all medicine companies to provide details on any “innovative medicine” produced by them.
The ministry has asked the companies to appoint a vigilance officer, who would inspect innovative pharmaceutical products containing active substances registered for the first time.
The vigilance officer must be a doctor, pharmacist, drugs specialist or toxicologist and must have practical experience in monitoring reports of drug side effects, clinical studies and clinical pharmacology, Amin Al Amiri, executive director for medical practices and licenses at the UAE ministry of health said Wednesday.
